Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Breast cancer 60% more fatal for heart attack survivors | Statin use among PAD patients | Edwards & Abbott end patent dispute
Tuesday, July 14, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

Breast cancer 60% more fatal for heart attack survivors

The eye-opening study tracked more than 1,700 patients with early-stage breast cancer.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Breast cancer 60% more fatal for heart attack survivors

Share on Twitter Share on Facebook Share on Linkedin
The eye-opening study tracked more than 1,700 patients with early-stage breast cancer.
READ MORE >

SNMMI 2020: Imaging highlights connection between heart and kidneys in heart attack response

Researchers monitored how the heart and kidneys responded one day, three days, seven days and six weeks following an induced myocardial infarction. 

READ MORE >
Damaged Organ
Share on Twitter Share on Facebook Share on Linkedin

SNMMI 2020: Imaging highlights connection between heart and kidneys in heart attack response

Share on Twitter Share on Facebook Share on Linkedin
Damaged Organ
Researchers monitored how the heart and kidneys responded one day, three days, seven days and six weeks following an induced myocardial infarction. 
READ MORE >

'A missed opportunity': Statin use low among patients with peripheral artery disease

Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.

READ MORE >
The American College of Cardiology and American Heart Association have collaborated on a new update to the much-discussed 2021 chest pain guidelines. The American College of Emergency Physicians and Society for Cardiac Angiography and Interventions also contributed to the document.
Share on Twitter Share on Facebook Share on Linkedin

'A missed opportunity': Statin use low among patients with peripheral artery disease

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology and American Heart Association have collaborated on a new update to the much-discussed 2021 chest pain guidelines. The American College of Emergency Physicians and Society for Cardiac Angiography and Interventions also contributed to the document.
Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.
READ MORE >

Edwards Lifesciences, Abbott agree to end patent dispute

In a statement announcing the news, Edwards said it “considers this agreement a positive development."

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Edwards Lifesciences, Abbott agree to end patent dispute

Share on Twitter Share on Facebook Share on Linkedin
In a statement announcing the news, Edwards said it “considers this agreement a positive development."
READ MORE >

Medtronic’s new ICM gains FDA clearance, CE mark approval

The device is roughly one-third the size of a AAA battery.

READ MORE >
heart_rate.png
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s new ICM gains FDA clearance, CE mark approval

Share on Twitter Share on Facebook Share on Linkedin
heart_rate.png
The device is roughly one-third the size of a AAA battery.
READ MORE >

Featured Articles

COVID-related strokes carry a greater risk of disability, death

When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

COVID-related strokes carry a greater risk of disability, death

Share on Twitter Share on Facebook Share on Linkedin
stroke
When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.
READ MORE >

Slow heart rates reported in COVID-19 patients treated with lopinavir, ritonavir

Treating critically ill COVID-19 patients with a combination of lopinavir (LPV) and ritonavir (RTV) is associated with a significant risk of bradycardia, according to new research out of France.

READ MORE >
covid-19.jpg
Share on Twitter Share on Facebook Share on Linkedin

Slow heart rates reported in COVID-19 patients treated with lopinavir, ritonavir

Share on Twitter Share on Facebook Share on Linkedin
covid-19.jpg
Treating critically ill COVID-19 patients with a combination of lopinavir (LPV) and ritonavir (RTV) is associated with a significant risk of bradycardia, according to new research out of France.
READ MORE >

Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease

An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.

READ MORE >
Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.
Share on Twitter Share on Facebook Share on Linkedin

Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.
An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.
READ MORE >

In Other News

HHS allocates over $4B in relief to hospitals hit hard by the pandemic

One billion of the total will go toward specialty rural hospitals, urban hospitals with certain rural Medicare designations and providers in small metropolitan areas, the administration announced recently.

READ MORE >
covid-money
Share on Twitter Share on Facebook Share on Linkedin

HHS allocates over $4B in relief to hospitals hit hard by the pandemic

Share on Twitter Share on Facebook Share on Linkedin
covid-money
One billion of the total will go toward specialty rural hospitals, urban hospitals with certain rural Medicare designations and providers in small metropolitan areas, the administration announced recently.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme